New weekly shot could help shed pounds without diabetes
NCT ID NCT06714955
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-stage trial tested a new drug called BGM0504, given as a weekly injection, in 30 non-diabetic adults who were overweight or obese. The main goals were to check safety, how the body processes the drug, and any changes in weight. Participants received either a low dose, a higher dose, or a placebo for several weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BGM0504 injection
- What this could lead to
- If successful, this could lead to a new weekly injection for weight management in people who are overweight or obese.
- What could go wrong
- This is an early Phase 1 trial with only 30 participants, so results may not apply to everyone. The drug may cause side effects or fail to show meaningful weight loss.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-DIABETIC OVERWEIGHT OR OBESE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pharmaron CPC, Inc
Baltimore, Maryland, 21201, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.